Correlation Between Aerovate Therapeutics and DiaSorin SpA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and DiaSorin SpA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and DiaSorin SpA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and DiaSorin SpA, you can compare the effects of market volatilities on Aerovate Therapeutics and DiaSorin SpA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of DiaSorin SpA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and DiaSorin SpA.

Diversification Opportunities for Aerovate Therapeutics and DiaSorin SpA

0.93
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Aerovate and DiaSorin is 0.93. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and DiaSorin SpA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiaSorin SpA and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with DiaSorin SpA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiaSorin SpA has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and DiaSorin SpA go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and DiaSorin SpA

Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the DiaSorin SpA. In addition to that, Aerovate Therapeutics is 4.31 times more volatile than DiaSorin SpA. It trades about -0.12 of its total potential returns per unit of risk. DiaSorin SpA is currently generating about -0.12 per unit of volatility. If you would invest  10,788  in DiaSorin SpA on September 20, 2024 and sell it today you would lose (103.00) from holding DiaSorin SpA or give up 0.95% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy95.45%
ValuesDaily Returns

Aerovate Therapeutics  vs.  DiaSorin SpA

 Performance 
       Timeline  
Aerovate Therapeutics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
DiaSorin SpA 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in DiaSorin SpA are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating essential indicators, DiaSorin SpA may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Aerovate Therapeutics and DiaSorin SpA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aerovate Therapeutics and DiaSorin SpA

The main advantage of trading using opposite Aerovate Therapeutics and DiaSorin SpA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, DiaSorin SpA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaSorin SpA will offset losses from the drop in DiaSorin SpA's long position.
The idea behind Aerovate Therapeutics and DiaSorin SpA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Transaction History
View history of all your transactions and understand their impact on performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope